NL300663I2 - - Google Patents

Download PDF

Info

Publication number
NL300663I2
NL300663I2 NL300663C NL300663C NL300663I2 NL 300663 I2 NL300663 I2 NL 300663I2 NL 300663 C NL300663 C NL 300663C NL 300663 C NL300663 C NL 300663C NL 300663 I2 NL300663 I2 NL 300663I2
Authority
NL
Netherlands
Prior art keywords
recombinant
multimodal
potency
purifying
purification
Prior art date
Application number
NL300663C
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NL300663I2 publication Critical patent/NL300663I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
NL300663C 2007-07-11 2014-04-15 NL300663I2 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07112287 2007-07-11
PCT/EP2008/059094 WO2009007451A1 (en) 2007-07-11 2008-07-11 Purification of factor viii using a mixed-mode or multimodal resin
EP08786090A EP2167526B1 (en) 2007-07-11 2008-07-11 Purification of factor viii using a mixed-mode or multimodal resin

Publications (1)

Publication Number Publication Date
NL300663I2 true NL300663I2 (nl) 2016-09-22

Family

ID=38472947

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300663C NL300663I2 (nl) 2007-07-11 2014-04-15

Country Status (15)

Country Link
US (1) US8399620B2 (nl)
EP (1) EP2167526B1 (nl)
JP (1) JP5323072B2 (nl)
KR (1) KR101293504B1 (nl)
CN (1) CN101730707B (nl)
AT (1) ATE503763T1 (nl)
AU (1) AU2008274195B2 (nl)
BR (1) BRPI0814220B8 (nl)
CA (1) CA2692814A1 (nl)
DE (1) DE602008005885D1 (nl)
ES (1) ES2364118T3 (nl)
NL (1) NL300663I2 (nl)
PL (1) PL2167526T3 (nl)
RU (1) RU2493163C2 (nl)
WO (1) WO2009007451A1 (nl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009156430A1 (en) * 2008-06-24 2009-12-30 Octapharma Ag A process of purifying coagulation factor viii
AU2009284113B2 (en) 2008-08-21 2015-05-14 Octapharma Ag Recombinantly produced human factor VIII and IX
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
US8277649B2 (en) 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
HUE037943T2 (hu) * 2010-02-24 2018-09-28 Chiesi Farm Spa Eljárás rekombináns lizoszomális alfa-mannozidáz elõállítására és tisztítására
ES2596727T3 (es) 2010-03-30 2017-01-11 Octapharma Ag Procedimiento de purificación de un factor proteico de crecimiento G-CSF
RU2731720C2 (ru) 2010-03-30 2020-09-08 Октафарма Аг Способ очистки витамин к-зависимых белков, таких как коагуляционный фактор vii
JP5947802B2 (ja) * 2010-11-05 2016-07-06 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ミックスモードクロマトグラフィーによる抗体捕捉の最適化方法
WO2012082933A1 (en) 2010-12-15 2012-06-21 Baxter International, Inc. Eluate collection using conductivity gradient
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
EP2911759A1 (en) 2012-10-24 2015-09-02 Genzyme Corporation Elution of biomolecules from multi-modal resins using mes and mops as mobile phase modifiers
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
CN103396494B (zh) * 2013-04-27 2015-04-01 江苏省疾病预防控制中心 一种凝血因子ix的单克隆抗体
HUE038741T2 (hu) * 2013-05-06 2018-11-28 Sanofi Sa Folyamatos többlépéses eljárás antitestek tisztítására
MX2016017115A (es) * 2014-06-25 2018-01-12 Jhl Biotech Inc Metodos y reactivos para la purificacion de proteinas.
AU2015299224B2 (en) 2014-08-04 2019-06-20 Csl Limited Factor VIII formulation
EP3265483B1 (en) 2015-03-06 2019-12-11 CSL Behring Lengnau AG Modified von willebrand factor having improved half-life
GB201506117D0 (en) 2015-04-10 2015-05-27 Ge Healthcare Bio Sciences Ab Method for chromatography
GB201506113D0 (en) * 2015-04-10 2015-05-27 Ge Healthcare Bio Sciences Ab Method for chromatography
EP3205665A1 (en) * 2016-02-11 2017-08-16 Octapharma AG Method of separating factor viii from blood products
GB201617240D0 (en) * 2016-10-11 2016-11-23 Profactor Pharma Ltd Purification process
EP3994162A1 (en) 2019-07-04 2022-05-11 CSL Behring Lengnau AG A truncated von willebrand factor (vwf) for increasing the in vitro stability of coagulation factor viii
JP2023500953A (ja) 2019-11-11 2023-01-11 ツェー・エス・エル・ベーリング・レングナウ・アクチエンゲゼルシャフト 第ｖｉｉｉ因子に対する寛容を誘導するためのポリペプチド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302006D0 (sv) * 1992-10-02 1993-06-11 Kabi Pharmacia Ab Protein formulation
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
SE503424C2 (sv) * 1994-11-14 1996-06-10 Pharmacia Ab Process för rening av rekombinant koagulationsfaktor VIII
IL157309A0 (en) * 2003-08-07 2004-02-19 Applied Research Systems Method for the purification of a non-immunoglobulin protein
JP2008525381A (ja) * 2004-12-23 2008-07-17 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 関心のあるビタミンｋ依存性タンパク質を含んでなる組成物中におけるタンパク質混入物の量の減少
EP1707634A1 (en) * 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
WO2009156430A1 (en) 2008-06-24 2009-12-30 Octapharma Ag A process of purifying coagulation factor viii

Also Published As

Publication number Publication date
EP2167526B1 (en) 2011-03-30
CN101730707A (zh) 2010-06-09
RU2010103528A (ru) 2011-08-20
AU2008274195B2 (en) 2013-09-05
ES2364118T9 (es) 2014-05-19
JP2010533150A (ja) 2010-10-21
EP2167526A1 (en) 2010-03-31
CN101730707B (zh) 2014-12-17
ATE503763T1 (de) 2011-04-15
BRPI0814220B8 (pt) 2021-05-25
US8399620B2 (en) 2013-03-19
DE602008005885D1 (de) 2011-05-12
KR101293504B1 (ko) 2013-08-07
US20100204452A1 (en) 2010-08-12
RU2493163C2 (ru) 2013-09-20
JP5323072B2 (ja) 2013-10-23
ES2364118T3 (es) 2011-08-25
WO2009007451A1 (en) 2009-01-15
CA2692814A1 (en) 2009-01-15
BRPI0814220A2 (pt) 2015-01-06
BRPI0814220B1 (pt) 2019-09-17
KR20100051620A (ko) 2010-05-17
PL2167526T3 (pl) 2011-09-30
AU2008274195A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
NL300663I2 (nl)
MX343087B (es) Aislamiento y purificacion de anticuerpos usando la cromatografia de afinidad de proteina a.
AU2017263237A1 (en) GDF15 fusion proteins and uses thereof
MX2012004711A (es) Aislamiento y purificacion de los anticuerpos anti-il-13 al usar cromatografia de afinidad con proteina a.
WO2009147248A3 (en) Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
IL226717A (en) Isolated nucleic acids encoded by anti-beta human antibodies 7
MX2010005783A (es) Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas.
WO2007104529A3 (en) Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
MX2010000196A (es) Prevencion de reduccion de enlaces de disulfuro durante la produccion recombinante de polipeptidos.
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
MY162624A (en) Antibodies directed to her-3 and uses thereof
MX2020003798A (es) Metodos para la purificacion de arilsulfatasa a.
TW200715985A (en) Systems and methods for separating proteins from connective tissue
EP3889164A4 (en) DEPROTECTION METHODS AND RESIN REMOVAL METHODS IN THE SOLID PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND AND METHODS FOR PRODUCTION OF A PEPTIDE COMPOUND
NZ781143A (en) Anti-vegf protein compositions and methods for producing the same
WO2004002418A3 (en) Compositions and methods comprising protein activated receptor antagonists
WO2010142551A8 (en) Amino acid sequences directed against receptors to cytokines belonging to the il-17 family
JO2991B1 (ar) بروتينات رابطة لمولد ضد المستقبل ايه للانترليوكين 17
WO2007063129A3 (en) Insolation of peptides , polypeptides and proteins
DE502004007067D1 (de) Verfahren zur herstellung zyklischer moleküle
EP1984013A4 (en) CST II MODIFICATIONS FOR INCREASED PROTEIN EXPRESSION
EP1870454A4 (en) PROCESS FOR DIPEPTIDE PRODUCTION
EP4169938A4 (en) RECOMBINANT PROTEIN PURIFICATION METHOD
GB2469395A (en) Methods and compounds for phototransfer
SG11202107201YA (en) Process for producing, isolating, and purifying modified recombinant proteins